Sinopharm Group Co., Ltd. is a distributor of pharmaceutical and healthcare products and a value added supply chain service provider in the People's Republic of China. The company is headquartered in Shanghai, Shanghai and currently employs 100,251 full-time employees. The company went IPO on 2009-09-23. The firm operates its business through four segments. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services to domestic and foreign pharmaceutical and health product manufacturers and other suppliers. The Device Distribution segment distributes medical devices to customers. The Pharmaceutical Retail Business segment owns a network of retail pharmacies that are directly operated or franchised. The Other Business segment is engaged in the manufacture and sale of pharmaceuticals, chemical reagents and laboratory supplies.
Follow-Up Questions
SHTDY 주식의 가격 성능은 어떻습니까?
SHTDY의 현재 가격은 $11.86이며, 전 거래일에 decreased 0% 하였습니다.
Sinopharm Group Co Ltd의 주요 사업 주제나 업종은 무엇입니까?
Sinopharm Group Co Ltd은 Health Care 업종에 속하며, 해당 부문은 Health Care입니다
Sinopharm Group Co Ltd의 시가총액은 얼마입니까?
Sinopharm Group Co Ltd의 현재 시가총액은 $37.0B입니다
Sinopharm Group Co Ltd는 매수, 매도, 아니면 보유해야 하나요?
월스트리트 분석가들에 따르면, 19명의 분석가가 Sinopharm Group Co Ltd에 대한 분석 평가를 실시했으며, 이는 5명의 강력한 매수, 10명의 매수, 6명의 보유, 0명의 매도, 그리고 5명의 강력한 매도를 포함합니다